Skip to main content
Home

Leading the Debate on the Advances in Healthcare

Connect with us

  • Facebook
  • Twitter
  • Linkedin
  • Google+
  • User Login
  • Register

Search Site

  • Home
  • About
    • About Us
    • Testimonials
    • Press Releases
  • Journals
    • European Oncology & Haematology
    • Oncology & Hematology Review (US)
    • Articles
    • Information for Authors
    • Information for Peer Reviewers
    • Permissions
    • Submit Here
  • Editorial Board
  • Media Partners
  • Videos
    • All Videos
    • ASCO Highlights
    • ASH Highlights
    • ECCO Highlights
    • EHA Highlights
    • ESMO Highlights
    • SABCS Highlights
  • INSIGHTS
  • FDA Approves Osimertinib for First-Line Treatment of Metastatic NSCLC With Most Common EGFR Mutations
  • CheckMate 227 Reveals Tumour Mutational Burden as an Important and Independent Biomarker in Advanced NSCLC
  • FDA Approves Nivolumab/Ipilimumab Combination for Intermediate or Poor-Risk Advanced RCC
  • ESMO Immuno-Oncology Congress 2018: Abstracts
  • FDA Finalises Guidances to Accelerate the Development of Reliable, Beneficial NGS-Based Tests
  • EMA to Review Risk of Dosing Errors with Methotrexate

Specialties

  • Biosimilars
  • Breast Cancer
  • Diagnostics and Screening
  • Gastrointestinal Oncology
    • Colorectal Cancer
    • Stomach Cancer
    • Liver Cancer
    • Pancreatic Cancer
  • Geriatric Oncology
  • Genitourinary Cancers
    • Bladder
    • Kidney Cancer
    • Prostate
    • Renal
  • Gynecological Oncology
    • Ovarian
  • Haematological Malignancies
    • Leukaemia
      • Acute Myeloid Leukemia
      • Chronic Lymphocytic Leukemia
      • Chronic Myeloid Leukemia
    • Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Disorders
    • Myelodysplastic Syndromes
    • Stem Cell Transplantation
  • Haematology
  • Head and Neck
  • Immunotherapy
  • Lung Cancer
  • Melanomas
  • Neuroendocrine
  • Neuro-Oncology
  • Radiology
  • Radiotherapy
  • Sarcoma
  • Supportive Oncology
  • Thyroid Cancer

Media Partners

European Society of Surgical Oncology
International Cancer Study & Therapy Conference
American College of Radiation Oncology
NCRI Cancer Conference 4-6 November 2018
European CanCer Organisation (ECCO)
European Organisation for Research & Treatment of Cancer
Mayo Clinic
BMJ Masterclasses
Association of Community Cancer Centers
Cleveland Clinic
European School of Haematology
European Association for Cancer Research
European Oncology Nursing Society
All Media Partners
Colorectal Cancer – Management of Metastatic Disease
A Review of Sleep Concerns in Pediatric Sickle Cell Disease
Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options
Diagnosis and Work-up of Malignant Melanoma in the Age of Fine Needle Aspiration and Molecular Testing
Symptomatic Spinal Metastases from Intracranial High-grade Glioma – Report of Four Cases and Review of the Literature
The Management of Mucositis in 2005
Dynamic Targeting - Image-guided Radiation Therapy - A Revolution in Cancer Care
New Advances in the Chemotherapy of Metastatic Colorectal Cancer
Precision Imaging in Radiotherapy
Image-Guided Radiotherapy—A Case Study
Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers
Riedel’s thyroiditis masquerading as anaplastic thyroid carcinoma: a case report
A Comparison of Mineral Bone Graft Substitutes for Bone Defects
New Drugs in the Treatment of Germ Cell Tumours
Chemotherapy Combination Outcomes Differ for Aged, Younger Colon Cancer Patients
Chemotherapy for Early-stage High-risk Endometrial Cancer
Elacytarabine – A New Agent in the Treatment of Relapsed/Refractory Acute Myeloid Leukaemia
Trends in the Treatment of Colorectal Cancer
Novel Biologically Based Therapies for Multiple Myeloma
The Role of Surgery in the Treatment of Gynecologic Cancers—A Shifting Paradigm
Epidemiology of Prostate Cancer
Advances in the Surgical Treatment of Lung Cancer
Accelerated Partial Breast Irradiation for Early-stage, Low-risk Breast Cancer
Topical Agents for the Management of Oral Complications in Cancer Patients
Therapeutic Strategies for the Treatment of Metastatic Melanoma—What is New is Old
A Synopsis of Cancer-related Anorexia and Weight Loss
Evaluating the Addition of Total Androgen Suppression to Radiation versus Radiation Alone for Locally Advanced Prostate Cancer
Metastatic Breast Cancer—Opportunities from Novel Diagnostic Modalities
Patient Selection for Prostate Brachytherapy
Computed Tomography and Position Emission Tomography in Radiation Oncology
The Fall of Tamoxifen?
Issues in Nutrition, Weight, and Cancer—An Overview for Clinicians
Psycho-oncology
Conformal Radiation
Bone Metastases in Advanced Prostate Cancer
Erythropoietic Therapy for Cancer-related Anemia
Treatment of Pancreatic Cancer
Absence of Annexin I Expression in B-cell Non-Hodgkin's Lymphomas and Cell Lines
Multiple Myeloma: A New Paradigm in Cancer Therapy
The Clinical Value of Tumour Markers in Breast Cancer
Four-dimensional Cone Beam Computed Tomography-guided Radiotherapy for Lung Cancer Patients
The Role of Kilovoltage X-rays in the Treatment of Skin Cancers
Radiofrequency Ablation of Lung Tumours
Computed Radiography Digital Imaging Solutions for Radiation Therapy
Clinical Introduction of Image-guided Radiotherapy and Cone Beam Computed Tomography
Non-small Cell Lung Cancer – An Update for 2006
Permanent Low-dose-rate Prostate Brachytherapy
Novel Pharmacodiagnostics in Breast Cancer
Transcatheter Arterial Chemoembolisation (TACE) for HCC – Classic Concepts and Future Evolution
Tumour Markers in Bladder Cancer
Current Trends in the Treatment for Brain Metastasis
Antimicrobial Therapy and Prevention in Febrile Neutropenia
Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma
Radioimmunotherapy – A New Approach in the Management of Non-Hodgkin's Lymphoma
Human Papillomavirus Vaccination
Pain Treatment for Terminal Cancer Patients
Trastuzumab as an Adjuvant Therapy for HER-2-Positive Breast Cancer
Taxane Chemotherapy—Advances in Treatment for Breast Cancer
Reviewing the Epidemic of Lung Cancer
Current Strategies in the Treatment of Advanced Non-small Cell Lung Cancer
Screening for Colorectal Cancer in 2006—Advantages and Limitations of the Different Screening Options
Radioimmunotherapy—A New Approach in the Management of Non-Hodgkin's Lymphoma
Use of Plasma Octreotide Levels to Guide Sandostatin® LAR Dosing
Neoadjuvant Chemoradiation for Pancreatic Cancer
Childhood Leukemias—Diagnosis, Treatment and New Agent Testing
Updates and Controversies in the Adjuvant Treatment of Pancreas Cancer
Laparoscopic Radical Prostatectomy
Randomized, Double-blind, Phase II Trial of Gallium Nitrate Compared with Pamidronate for Acute Control of Cancer-Related Hypercalcemia
Minimally Invasive Surgery for Colorectal Cancer—An Update
Aromatase Inhibitors in Metastatic Breast Cancer
Aromatase Inhibitors – The New Standard for Postmenopausal Women with Hormone-responsive Breast Cancer
The Risk of Early Recurrence and Distant Metastases: Lessons from the Monotherapy Adjuvant Aromatase Inhibitor Trials with a Focus on BIG 1-98
Reducing the Risk of Late Relapse in Postmenopausal Women with Hormone-sensitive Breast Cancer – Extended Adjuvant Letrozole
Rational Use of Bisphosphonates for the Management of Patients with Breast and Prostate Cancer
Systemic Treatment in Colorectal Cancer
Radioembolisation – A New Treatment for Primary and Secondary Liver Tumours
Early Gastrointestinal Stromal Tumour Resection and Adjuvant Therapy with Imatinib
Managing Resistance to Gastrointestinal Stromal Tumours
Long-term Disease Control with Imatinib Treatment in Metastatic Gastrointestinal Stromal Tumours
Imatinib Efficacy in Gastrointestinal Stromal Tumours
Molecular Diagnostics for Haematological Cancer
Molecular Diagnostics and Risk-stratification in Chronic Lymphocytic Leukaemia
Molecular Diagnostics
Chemo-immunotherapy – The Role of Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukaemia
Therapeutic Options in Refractory or Relapsed CD20-positive Follicular Lymphoma
New Developments in the Treatment of Chronic Lymphocytic Leukaemia
Compensator-intensity-modulated Radiotherapy – Traditional Tool for Modern Application
Proton Beam Radiation Therapy – From Physics to Clinical Indications
Current Status of Four-dimensional Computed Tomography for High-precision Radiotherapy
The Impact of Darbepoetin Administration in Haemoglobin Levels and Quality of Life in Cancer Patients Undergoing Radiation Treatment
The TuBaFrost Project – A European Virtual Tumour Tissue Bank
The Role of Eicosapentaenoic Acid in the Treatment of Cancer Patients
Tumour Markers in Lung Cancer
The Risk of Early Recurrence and Distant Metastases
Role of Radiotherapy in Patients with Early Breast Cancer
Novel Management Strategies for Female Pelvic Cancers
Novel Agents in the Treatment of Lung Cancer
Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy for Diffuse Malignancy Peritoneal Mesothelioma
New Treatments for Advanced Gastric Cancer
Treatment of Advanced Epithelial Ovarian Cancer
Current Management of Bladder Cancer
Removing the Burden Iron Overload and Deferasirox (ICL670)
Consequences of Iron Overload in Myelodysplastic Syndromes
Compensator-intensity-modulated Radiotherapy—A Traditional Tool for Modern Application
Fiducial Markers in Image-guided Radiotherapy of the Prostate
Adjuvant Radiation Therapy for Locally Advanced Bladder Cancer
Iron Overload Screening and Diagnosis
Management of Breakthrough Pain in the Cancer Patient
Pharmaceutical Management of Cancer Breakthrough Pain
Nanotechnology in Personalized and Predictive Oncology
Long-term Enteral Nutrition Facilitates Optimization of Body Weight
Cancer and Nutrition—The Importance of Preventing Weight Loss Throughout the Treatment Continuum
Breast Cancer and Novel Therapeutic Treatments
Current Challenges in Human Epidermal Growth Factor Receptor-2-positive Breast Cancer – Treating Disease Progression
Challenges of Brain Metastasis in ErbB2 (HER-2-positive) Breast Cancer and the Potential of Small Molecules
Answers and Remaining Questions Regarding Systemic Treatments for Breast Cancer in the Elderly
Breast Cancer and Intra-operative Radiotherapy with Electrons at the European Institute of Oncology
New Aspects in the Epidemiology of Lung Cancer – The Women's Epidemic
Therapies in Metastatic Non-small-cell Carcinoma
The International Liver Cancer Association – The Scientific Answer to a Major Health Problem
Drug-eluting Beads in the Treatment of Cirrhosis-related Hepatocellular Carcinoma
Recurrent Prostate Cancer After Radiotherapy – Salvage Treatment by High-intensity Focused Ultrasound
Defining Risk for Early Detection of Oesophageal Adenocarcinoma – Finding the Needle in the Haystack
Long-term Chronic Myeloid Leukaemia Therapy
Tracking versus Gating in the Treatment of Moving Targets
Ibritumomab Radioimmunotherapy in Mantle Cell Lymphoma
The International Society of Geriatric Oncology Task Force on Bisphosphonates in Elderly Patients
Alemtuzumab as First-line Treatment for Progressive B-cell Chronic Lymphocytic Leukaemia
Image-guided Radiotherapy
Management of Recurrent or Progressive Glioblastoma Multiforme with Low-intensity, Medium-frequency Alternating Electric Fields
Results of Neoadjuvant Radiochemotherapy in Advanced Oral-cavity Tumours
Cancer-related Nutrition
Improved Cancer Care Puts Focus on Specialist Education and Training in Surgical Oncology
Targeting the Epidermal Growth Factor Receptor in Colorectal Cancer
Picture Archiving and Communication Systems as an Element of Digital Information and Image Management in Radiation Oncology
Venous Thromboembolism and Cancer – Still an Underestimated Problem in Medical Cancer Patients?
Living with Cancer-related Anaemia – What Is the Reality?
Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
Current Therapies for Metastatic Brain Tumors
Current Management of High-grade Astrocytic Neoplasms—Small but Tangible Progress
The Role of Radiosurgery in the Management of Brain Metastases
State-of-the-art Therapy for Glioblastoma Multiforme
Surgical Staging of Ovarian Low Malignant Potential Tumors
Aromatase Inhibitor-associated Bone Loss in Breast Cancer
The Importance of Distant Metastasis and Its Impact on Survival Rates on Early-stage Hormone Receptor-positive Breast Cancer
Adjuvant Treatment of Breast Cancer in Older Patients
The Use of Doxil® (Caelyx®) for the Treatment of Prostate Cancer—Past, Present, and Future
Therapeutic Approach to Hormone-refractory Prostate Cancer
Computed Tomography Scanning for Lung Cancer 2007—Notes to Clinicians and Glimpses of the Future
Image-guided Radiotherapy for Early-stage Medically Inoperable Non-small-cell Lung Cancer
Nilotinib in Chronic-phase Chronic Myeloid Leukemia
Advances in Pancreatic Cancer Treatment
IRIS at Five Years Still Changing the Face of Long-term Chronic Myeloid Leukemia Therapy
The Emerging Synergy between Radioembolization, Systemic Chemotherapy, and Liver Surgery in Metastatic Colorectal Cancer
Strategies for Image-guided Proton Therapy of Cancer
Optimization of Therapy for Acute Myeloid Leukemia
Therapy of Myelodysplastic Syndrome
Histone Deacetylase Inhibition in Hematological Malignancies
Dose Verification System Radiation Detector for Radiation Therapy
The Pain of Oral Mucositis
Functional Imaging in the Modern Radiation Oncology Practice—The Role of Positron Emission Tomography/Computed Tomography-based Treatment Planning
The Role of Nutritional Supplements in the Treatment of Cachexia in Cancer Patients—The Registered Dietician's Perspective
Intra-operative Radiotherapy for Early Breast Cancer
Radioactive Microspheres for Liver Cancers
Modern Radiotherapy—Exploiting Technology Integration
Combined External Beam Radiotherapy and Brachytherapy for the Management of Prostate Cancer
Realtime Method to Locate and Track Targets in Radiotherapy
Advances in Image-guided Radiotherapy—The Future is in Motion
Controlling Breast Cancer
Radioimmunotherapy—A New Approach in the Management of Non-Hodgkin's Lymphoma
Cognitive Effects of Cancer Therapies
Targeting the Tumor—Translating Genetic and Molecular Profiling into Clinical Reality
Cryoablation of Early-stage Breast Cancer
The Case for the Role of Chronic Inflammation in the Development of Prostate Cancer
Mediastinal Endoscopic Ultrasound-guided Fine Needle Aspiration
Radiofrequency Ablation—A New Treatment Option for Non-small Cell Lung Cancer Patients
Glioblastoma Multiforme—Past, Present, and Future
Bone Metastases in Breast Cancer
Neuroendocrine Gastroenteropancreatic Tumors—Recent Update on Diagnosis and Treatment
Transcatheter Arterial Chemoembolisation for the Treatment of Hepatocellular Carcinoma
Ductoscopy-guided and Conventional Surgical Excision
Breast Preserving Therapy with Single Fraction Intraoperative Radiotherapy
Pediatric Urologic Oncology
Treatment of Inoperable Liver Cancers with Radioactive Microspheres
Modulated Radiotherapy—Current Status and New Developments
High-precision Radiotherapy
Magnetic Resonance Imaging Gaining Importance in Breast Cancer High-risk Screening and Disease Management
Long-term Survival Advantage for Recurrent Ovarian Cancer Patients Receiving Pegylated Liposomal Doxorubicin
Progress in the Treatment of Advanced Non-small Cell Lung Cancer
Current Treatment of Brain Metastases
Use of Electromagnetic Technology for Four-Dimensional Radiotherapy Localisation and Realtime Tumour Tracking
The Impact of Taxotere on Adjuvant Breast Cancer
Computed Tomography Colonography for the Detection of Colorectal Cancer
Practical Considerations in Bone Metastases in Breast Cancer
Proteomics-derived Biomarkers for Early Detection of Bladder Cancer
Diagnosis of Invasive Fungal Infections – Current Limitations of Classical and New Diagnostic Methods
Image-guided Radiofrequency Ablation of Hepatocellular Carcinoma and Colorectal Hepatic Metastases – Long-term Survival Outcomes
Twenty Years of Prostate-specific Antigen – An Historical View
Chemotherapy Treatment Options for Non-small-cell Lung Cancer
Emerging and Life-threatening Fungal Pathogenes in the Immunocompromised Host
Preventing Premature Death from Breast Cancer
Clinical use of Four-dimensional Computed Tomography Scans
Tumour Markers in Bladder Cancer
A Primary Pancreatic Carcinoid Tumor with Unusual Clinical Complaints—A Case Report
Colony Stimulating Factors in Solid Tumor Cancer and Acute Leukemia
Management of Chemotherapy-induced Neutropoenia
Transdermal Buprenorphine in the Management of Cancer Pain
Facing the Challenges of the European Clinical Trials Directive – The European Organisation for Research and Treatment of Cancer Perspective
The Challenge of Eliminating Tobacco-induced Cancers in the Developing World
The Role of Alemtuzumab in the Management of Chronic Lymphocytic Leukaemia – Which Patients and When?
First-line Treatment for Chronic Lymphocytic Leukaemia – The Time for Alemtuzumab?
Consolidation Therapy for Follicular Lymphoma
Clinical Experience of Nadroparin in Patients with Cancer
Review of the Response Criteria for Myelodysplastic Syndrome
State of the Art in the Use of Gene Expression Technologies for Breast Cancer Management
Predicting Metastatic Behaviour in Lung Adenocarcinoma
Detection of Oral Pathologies Using Optical Coherence Tomography
Tailoring Treatment Decision-making in Metastatic Breast Cancer
Colorectal Liver Metastases – Enhancing Outcomes Through Combination Treatments
Debates on Treatment Order of Colorectal Cancer with Liver Metastases
Using Epirubicin-loaded DC Beads® for Superselective Embolisation of Liver Tumours – Initial Experiences
The Challenges of Treating Cancer in Older Patients – How Effective Are Clinical Trials in Developing Unique Treatments?
Biology- not Chronology-driven Treatment of Breast Cancer in the Elderly
Inhibitors in Haemophilia A – Ongoing Research and Clinical Practice
Snake Venom and Haemostasis – An Overview
Awareness of Mild Bleeding Disorders
Advances in the Treatment of Metastatic Melanoma Through Radiotherapy
Novel Treatment Approaches for Managing Early-stage Breast Cancer – Maximising Safety and Outcome with Adjuvant Taxane-containing Chemotherapy Regimens
The Challenge of Breast Cancer in Low- and Middle-income Countries – Implementing the Breast Health Global Initiative Guidelines
Haemophilia Treatment – Current and Future Challenges
Advances in Treatment Options for Patients with Pancreatic Cancer
Advances in the Treatment of Castration-resistant Prostate Cancer
Optimal Therapy for Multiple Myeloma
Unmet Needs in the Treatment of Metastatic Non-small-cell Lung Cancer
The Use of Magnetic Resonance Imaging to Accurately Establish the Clinical Staging of Squamous Cell Carcinoma in the Head and Neck
Current Management of von Willebrand Disease
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis
Low-molecular-weight Heparins in the Management of Cancer-associated Thrombosis
Novel Approaches to Taxane-based Chemotherapy Regimens in Lung Cancer
The International Union Against Cancer – Global Cancer Control
Proteomics in Myeloproliferative Disorders
Modulating Factors in Cervical Carcinogenesis
Quality of Life of Filipino Cancer Patients
Romiplostim – A Thrombopoiesis-stimulating Peptibody for the Management of Chronic Immune Thrombocytopenic Purpura in Adults
Antitumour Effect of Vitamin K2 on Hepatocellular Carcinoma
Challenges in the Practice of Geriatric Oncology in a National Comprehensive Cancer Centre in Asia
Therapeutic Approach to Castration-resistant Prostate Cancer
Chemotherapy-induced Anaemia
Management of Multiple Myeloma
The Effect of Systemic Treatment on Patient Survival of Soft-tissue Sarcoma
Therapies in Metastatic Non-small-cell Lung Carcinoma
Novel Cytotoxic Agents in Chemotherapy-resistant Metastatic Breast Cancer – The Epothilones
Developments in Breast Cancer Treatment – Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibitors
The Harmful Effects of Iron Overload in Patients with Myelodysplastic Syndrome
Developments in the Treatment of Pancreatic Cancer
Non-steroidal Anti-inflammatory Agents – Benefits and New Developments for Cancer Pain
Epothilones – Expanding the Options for Breast Cancer?
Treatment of Bone Tumours by Radiofrequency Thermal Ablation
Beyond Anthracyclines and Taxanes – Epothilones for Metastatic Breast Cancer
Management of Chemotherapy-induced Neutropenia with Colony-stimulating Factors
Regional Chemotherapy via Transarterial Chemoembolisation in Colorectal Liver Metastases
The Promise of Biological and Molecular-orientated Treatments for Colon Cancer
New Developments in Oesophageal Adenocarcinoma Treatment
The Clinical Value of Radioembolisation in the Treatment of Inoperable Liver Cancer
The Future of Therapy for Advanced Renal Cell Cancer
The Role of Radioembolisation Using SIR-Spheres® in Secondary Liver Metastases of Non-colorectal Cancer Origin – Emerging Clinical Data
Chemotherapy-induced Nausea and Vomiting
Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer
A Focus on the Treatment of Anthracycline Extravasation and Tissue Protection
Multimodality Approaches to Improving Post-operative Pain and Outcomes
Advances in the Prognosis and Treatment of Medullary or Anaplastic Thyroid Cancer
Advances in Chemotherapy Options for Head and Neck Cancer
Benefits of Vorinostat in Treating Advanced Cutaneous T-cell Lymphoma
Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines
A Practical Clinical Approach to Adjuvant Therapy in Breast Cancer—An Update
Psycho-education for Breast Cancer Patients and Survivors— A Powerful Tool for Healthcare Providers
The Role of Imatinib Following Complete Resection of Primary Gastrointestinal Stromal Tumors
The Efficacy of Imatinib in Unresectable/Metastatic Gastrointestinal Stromal Tumors
Advances in Treatment Options for Patients with Pancreatic Cancer
The Clinical Value of Radioembolization in the Treatment of Inoperable Liver Cancer
Colorectal Liver Metastases—Enhancing Outcomes Through Combination Treatments
Therapeutic Approach to Castration-resistant Prostate Cancer
Laparoscopic Radical Hysterectomy for Early-stage Cervical Cancer
Advances in the Treatment Options for Kidney Cancer— Is There an Optimal Regimen?
Is There an Optimal First-line Regimen for Advanced Ovarian Cancer? Variations on a Theme
Disparities in Cancer Diagnosis, Treatment, and Survival Between African-American and Other Population Groups
A gastrointestinal stromal tumour presenting incidentally with haemorrhage and perforation associated with a Meckel’s diverticulum: a case report
Gliomatosis cerebri type II: two case reports
Management dilemma of a recurrent huge fibrosarcoma in a 25-year-old African: a case report
Sublingual Fentanyl (Abstral®) for Breakthrough Cancer Pain
Therapeutic Armamentarium in Metastatic Colorectal Cancer
Managing Anthracycline Extravasations and Protecting Tissue
Availability and Accessibility of Opioids in Developing Countries, with Special Reference to Eastern Europe
Gliosarcoma – Clinico-pathology, Genetics and a Review of Rare Congenital Cases
Recent Advances in Oral Oncology
Palliative Orthopaedic Surgery for Skeletal Metastases
Second- and Third-line Treatment in Advanced Non-small-cell Lung Cancer
Interventional Radiology in Skeletal Metastasis
Locoregional Therapy in Breast Cancer
The German Breast Group – Healing Through Innovation, Competence and Partnership
European Audit on Colorectal Cancer Treatment Outcome – The Next Step in Quality Assurance Initiated by the European Society of Surgical Oncology
Improving the Outcome of Patients with Castration-resistant Prostate Cancer Through Rational Targeting of the Androgen Receptor
Maternal Epithelial Ovarian Cancer
The Role of Imaging in Advanced Endometrial Carcinoma
Capturing Alloreactivity in Multiple Myeloma
Development of Oncogeriatry – A European Perspective from the French Experience
The Epidemiology of Childhood Cancers
Sebaceous carcinoma of the skin of the breast: a case report
Metastatic gastric cancer presenting with shoulder-hand syndrome: a case report
Malignant melanoma of the rectum: a case report
Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report
Primary hepatic lymphoma presenting as fulminant hepatic failure with hyperferritinemia: A case report
Efficacy and Safety of Deferasirox
Overview of Current Treatment Regimens in Iron Chelation Therapy
Iron Overload and Iron Chelation Therapy in Pediatric Patients
Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia—Is There an Optimal Treatment Plan?
Should Patients with Myelodysplastic Syndromes Undergo Iron Chelation Therapy? New Data Answering the Question
Nilotinib Therapy in Patients with Chronic Myeloid Leukemia Who Have Failed Imatinib
Identification and Functional Characterization of von Willebrand Disease
The Management of Paroxysmal Nocturnal Hemoglobinuria—Recent Advances in Diagnosis and Treatment, and New Hope for Patients
Rhesus Gene Family and Blood Group Antigens—Molecular Aspects in Relation to Genomic Transfusion Medicine
Appropriate Use of Vena Cava Filters
Malignancy Following Solid Organ and Hematopoietic Stem Cell Transplantation
Genome-wide Studies in Childhood Acute Lymphoblastic Leukemia
Education, Mentoring, and Collaborative Research—The Mission of the Hemophilia & Thrombosis Research Society
Platelet–Leukocyte Interactions in Inflammation and Thrombosis
Budesonide versus Placebo in a High-risk Population with Screen-detected Lung Nodules
Comparative Efficacy of Reduced or Standard Doses of Lenograstim for Peripheral Blood Stem Cell Mobilisation and Transplantation – A Review
BRAFV600E as a Therapeutic Target in Colorectal Cancer
Maintenance Chemotherapy for Advanced Non-small-cell Lung Cancer
The Neurogenic Component of Cutaneous Toxicities Induced by Chemotherapy – New Solutions
The Use of Patient-reported Outcomes at an Individual Level – Benefits and Challenges
Fertility Preservation Options for Patients with Cancer
Evolution of the 21-gene Assay Oncotype DX® from an Experimental Assay to an Instrument Assisting in Risk Prediction and Optimisation of Treatment Decision-making in Early Breast Cancer
Immune Self-tuning in Renal Cell Carcinoma
The European Organisation for Research and Treatment of Cancer Imaging Programme
Treatment of Hepatocellular Carcinoma – Integrating Loco-regional and Molecular-targeted Therapies
Novel Strategies to Improve the Efficacy of Anticancer Agents in Human Colorectal Carcinoma
The Newly Diagnosed Myeloma Patient – Therapeutic Approaches
Potential of a New Blood Test for Colorectal Cancer Screening –The Septin 9 Gene Biomarker
Anti-natural Killer Inhibitory Receptors in Elderly Patients with Acute Myeloid Leukaemia
Local Control of Metastatic Spinal Cord Compression Following Radiotherapy
Survivin-directed Anticancer Therapies – A Review of Pre-clinical Data and Early-phase Clinical Trials
Targeted Therapy in Combination with Chemotherapy in Recurrent and/or Metastatic Head and Neck Cancer
Treatment Strategies in Metastatic Renal Cell Carcinoma
Liver Resection of Colorectal Metastases in Elderly Patients
Antifungal Treatment in the Blood and Marrow Transplant Setting – Perspectives from Clinical Experience
Role of Epidermal Growth Factor Receptor Mutational Testing in Personalising the Treatment of Non-small-cell Lung Cancer
Partial Breast Irradiation as an Alternative to Whole Breast Radiation
Colorectal Carcinoma in the Post-liver-transplant Setting – A Short Overview
Men’s Health – Time to Change Our Approach
Worldwide Use of Internet-based Survivorship Care Plans
Diagnosis of Lung Cancer – Improving Survival Rates
Treatment of Chemotherapy-induced Nausea in Cancer Patients
Video-endoscopic Inguinal Lymphadenectomy
Squamous Cell Vulval Carcinoma and Pregnancy – A Review
Magnetic-resonance-guided Focused Ultrasound Surgery in the Treatment of Oncology Patients – Fundamentals and Review of Early Clinical Applications
Myelodysplastic Syndromes in the Elderly – A Prominent Medical Concern with Significant Effects on Healthcare Systems
Current First-line and Salvage Treatment Strategies in Patients with Advanced-stage Follicular Lymphoma
Pre-operative Targeted Therapies in Patients with Hepatic Colorectal Cancer Metastases—Bevacizumab versus Cetuximab
The Neurogenic Component of Cutaneous Toxicities Induced by Chemotherapy—New Solutions
Exercise and Cancer-related Fatigue
Role of Epidermal Growth Factor Receptor Mutational Testing in Personalizing the Treatment of Non-small-cell Lung Cancer
Cisplatin plus Cetuximab in the Treatment of Recurrent and Persistent Cancers of the Cervix
Autologous Stem Cell Transplantation—An Important Step Toward Improving Survival in Multiple Myeloma
Management of Cancer-related Cognitive Dysfunction—Conceptualization Challenges and Implications for Clinical Research and Practice
Buckle Up for Breast Cancer—Deaths from Breast Cancer Can Be Analyzed in the Same Way as Deaths in Automobile Accidents
Pancreatic Adenocarcinoma in the Older Adult
Adolescent Psychopathology and Adult Health Behaviors in Long-term Survivors of Childhood Cancer
Survival of Patients Treated with High-dose Radiotherapy and Concurrent Chemotherapy for Unresectable Non-small-cell Lung Cancer
Denosumab in the Treatment of Giant Cell Tumor of Bone
Chemotherapy-induced Oral Mucositis
Breakthrough Pain in Cancer Patients— Characteristics, Impact, and Assessment
Feasibility of New-generation Infrared Imaging Screening for Breast Cancer in Rural Communities
Breakthrough Pain in Cancer Patients— Pharmacologic Symptomatic Treatment
Accelerated Partial Breast Irradiation and Hypofractionated Whole Breast Radiation
Multidrug Combinations for First-line Therapy of Advanced Non-small-cell Lung Cancer
Fertility and Cancer—Patient, Physician, and Institutional Barriers
Localized Prostate Cancer—What the Medical Oncologist Needs to Know
Treating Endometrial Adenocarcinoma— Do Data Support the Use of Pegylated Liposomal Doxorubicin?
Relevance of Weight Loss, Splenomegaly, and Hypocholesterolemia in the Treatment of Myeloproliferative Neoplasms— Implications for a JAK2 Inhibitor Era
The Effect of Sickle Cell Genetic Markers on Geographic Distribution and Relation to Pain Outcomes in the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
Inflammation and Acute Venous Thrombosis
Peripheral Blood Hematopoietic Stem-cell Mobilization for Autologous Transplantation
Platelet Activation Following Exposure to Anti-ABO Antibodies— An In Vitro Study
Cetuximab in the Treatment of Locally Advanced Head and Neck Cancer
Breast Magnetic Resonance Imaging of Multicentric, Multifocal and Bilateral Cancer – A Case-based Review
The Neurogenic Component of Cutaneous Toxicities Induced by Chemotherapy – New Solutions
The Challenge of Mediastinal Staging
Surgical Treatment of Pancreatic Cancer
Endocrine Complications in Children Treated for Medulloblastoma or Ependymoma using Radiation Therapy – Outcomes in the Computed Tomography Planning Era
Magnetic Resonance Imaging Findings of Radiation-induced Changes After Treatment of Malignant Gliomas and Metastases with a Particular Emphasis on Radiation Necrosis
Leukaemic Transformation of Philadelphia-chromosome-negative Myeloproliferative Neoplasms – A Review of the Molecular Background
The Emergence of Thrombopoietin Receptor Agonists as a Novel Treatment for Immune Thrombocytopenia
Evidence Supporting the Use of Recombinant Activated Factor VII in Congenital Bleeding Disorders
Musculoskeletal Pathologies in Children with Haemophilia Evaluated using a Standardised Physical Joint Scoring System to Assess Disability
Inflammation and Thrombosis – Brothers in Arms
Difficult Decisions in Cancer Care – Conducting an Ethics Case Analysis
The Clinical Pharmacology of Anastrozole
Image-guided Radiotherapy Based on Kilovoltage Cone-beam Computed Tomography – A Review of Technology and Clinical Outcome
Hormonal Treatment of Metastatic Endometrial Stromal Sarcomas
The Evolving Role of Chemotherapy and Predictive Markers in Early-stage Non-small-cell Lung Cancer
Platelets – From Function to Dysfunction in Essential Thrombocythaemia
New Treatment Approaches in Chronic Kidney Disease-associated Anaemia
Subnormal Vitamin B12 Concentrations and Anaemia in Older Persons
Recombinant Factor VIIa Concentrate versus Plasma-derived Concentrates for the Treatment of Acute Bleeding Episodes in Persons with Haemophilia and Inhibitors
Long-term Efficacy of Rituximab Treatment in Thrombotic Thrombocytopenic Purpura
The HemoRec Database as an Example of a Rare Diseases Registry
Efficacy and Safety of Radioiodine in the Treatment of Disseminated Differentiated Thyroid Cancer in Children
Unmet Needs in the Treatment of Metastatic Non-small-cell Lung Cancer
Therapeutic Approach to Castration-resistant Prostate Cancer
Systemic Targeted Radionuclide Therapy—Positioned for a Take-off
Any Progress in 2006 in Breast Cancer in the Elderly?
Pregnancy After Breast Cancer
The Challenge of Eliminating Tobacco-induced Cancers in the Developing World
Trastuzumab as an Adjuvant Therapy for HER-2-Positive Breast Cancer
Recurrent Prostate Cancer After Radiotherapy – Salvage Treatment by High-intensity Focused Ultrasound
Chemo-immunotherapy – The Role of Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukaemia
Any Progress in 2006 in Breast Cancer in the Elderly?
Reducing the Risk of Late Relapse in Postmenopausal Women with Hormone-sensitive Breast Cancer—Extended Adjuvant Letrozole
Managing Resistance to Gastrointestinal Stromal Tumours
Imatinib Efficacy in Gastrointestinal Stromal Tumours
Early Gastrointestinal Stromal Tumour Resection and Adjuvant Therapy with Imatinib
The International Society of Geriatric Oncology Task Force on Bisphosphonates in Elderly Patients
Long-term Disease Control with Imatinib Treatment in Metastatic Gastrointestinal Stromal Tumours
Adjuvant Treatment of Breast Cancer in Older Patients
The Emerging Synergy between Radioembolization, Systemic Chemotherapy, and Liver Surgery in Metastatic Colorectal Cancer
Nilotinib in Chronic-phase Chronic Myeloid Leukemia
Current Status of Four-dimensional Computed Tomography for High-precision Radiotherapy
Aromatase Inhibitor-associated Bone Loss in Breast Cancer
The Importance of Distant Metastasis and Its Impact on Survival Rates on Early-stage Hormone Receptor-positive Breast Cancer
Clinical Introduction of Image-guided Radiotherapy and Cone Beam Computed Tomography
Image-guided Radiofrequency Ablation of Hepatocellular Carcinoma and Colorectal Hepatic Metastases—Long-term Survival Outcomes
Preventing Premature Death from Breast Cancer
Advances in Image-guided Radiotherapy – The Future is in Motion
Transcatheter Arterial Chemoembolisation for the Treatment of Hepatocellular Carcinoma
Radioimmunotherapy – A New Approach in the Management of Non-Hodgkin Lymphoma
Colony Stimulating Factors in Solid Tumor Cancer and Acute Leukemia
Long-term Survival Advantage for Recurrent Ovarian Cancer Patients Receiving Pegylated Liposomal Doxorubicin
Reimbursement Issues for Oncology Drugs
Advances in Radiation Therapy
Treatment Strategies and Practice Guidelines in Geriatric Oncology
The Challenges of Academic Cancer Clinical Research in Europe
The Strength of Unity in Oncology
Geriatric Oncology – A Challenge for the Future
The Year Ahead – A Preview to The European Cancer Conference
The Value of Free PSA in Addition to Total PSA in the Early Detection of Prostate Cancer
Neuroendocrine Gastroenteropancreatic Tumours – Current Views on Diagnosis and Treatment
Challenges of Cancer Research in Europe – The Case of Translational Research
Information Management in Oncology
The Price of Successful Research
Clinical Cancer Research in Europe – Plenty of Opportunities to be in the Lead
Radiofrequency Ablation of Lung Tumours
Guidelines for Best Practice – The Patient Advocate’s Viewpoint
Nutritional Management and Dietary Guidelines for Cancer Cachexia
The International Union Against Cancer
Challenges in Paediatric Oncology at the Onset of the 21st Century
Z-BEAM Transplantation
New Haematological Indications for Imatinib
The Combination of Xanafide and Cytarabine Has Unique Activity in Acute Myeloid Leukaemia
Treatment of Multiple Myeloma Patients Who Have Received at Least One Prior Therapy
Targeting the ErbB Family in Head and Neck Cancer
Locally Advanced Squamous Cell Cancer of the Head and Neck – Targeting Epidermal Growth Factor Receptor
Targeted Therapy for Oesophageal Cancer
Breast Cancer and Novel Therapeutic Treatments
Triple-negative Phenotype in Metastatic Breast Cancer – Where Do We Stand in Terms of Treatment?
Advances in Breast Cancer Treatment
Advances in Diagnosis of Early Lung Cancer
Gastrointestinal Stromal Tumours in the Era of Imatinib – An Overview
Therapeutic Treatment of Hepatic Colorectal Metastases
Advances in Interventional Radiology in the Treatment of Primary and Metastatic Liver Cancer
Current Treatment Standards in Metastatic Colorectal Cancer – The Role of Anti-epidermal Growth Factor Antibodies
Neoadjuvant Treatment for Liver Metastases of Colorectal Cancer
The Management of Colorectal Cancer – The Integration of Biological Agents and Identification of New Targets
Topotecan Weekly versus Topotecan Five-day Schedule in Patients with Platinum-resistant Ovarian Cancer – Which Is the Best Regimen?
Defining Optimal Treatment in Early-stage Epithelial Ovarian Cancer – When, What and for How Long?
First-line Chemotherapy in Patients with Advanced Ovarian Cancer
Current Treatment Strategies for Malignant Gliomas
High-dose-rate Brachytherapy of Prostate Cancer
Current Status of Oblimersen (Bcl-2 Antisense) Therapy for Advanced Melanoma
Recent Advances in Dermoscopic Diagnostic Technologies
Contrast-enhanced Ultrasound in Prostate Cancer
Diagnostic Imaging Approaches to Prostate Cancer
Salivary Flow and Intensity-modulated Radiation Therapy
Strategies for Image-guided Proton Therapy of Cancer
Regional Hyperthermia as Targeted Therapy in the Management of High-risk Soft-tissue Sarcoma
New Minimally Invasive Approaches to Early Cancer Detection
Current Considerations in Managing Chemotherapy-induced Nausea and Vomiting
Developments in Breast Cancer Treatment – Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 Inhibitors
The Challenge of Breast Cancer in Low- and Middle-income Countries— Implementing the Breast Health Global Initiative Guidelines
Bridging the Gap Between Populations—The Challenge of Reducing Cancer Disparities Among African-Americans and Other Ethnic Minority Populations
Selective Internal Radiation Therapy—Tackling the Tumor, Sparing the Organ
Gene Expression and Targeted Therapies— New Developments in Melanoma Treatment
Malignant Pleural Mesothelioma—A Current Review
The Current Role of Sentinel Lymph Node Biopsy in Breast, Melanoma, and Gastrointestinal Cancers
The p53 Tumor-suppressor Gene—Inhibiting Tumor Angiogenesis
Chemotherapy-induced Nausea and Vomiting
Predicting Metastatic Behavior in Lung Adenocarcinoma
Unmet Needs in the Treatment of Metastatic Non-small-cell Lung Cancer
Androgen-deprivation Therapy— A Help or a Hindrance for Survival in High-risk Prostate Cancer?
Maintaining Bone Health and Integrity During Androgen-deprivation Therapy for Prostate Cancer
Developing Treatments for Hormone-refractory Prostate Cancer
Salvage Cryosurgery in Prostate Cancer
Phenoxodiol—A Chemosensitizer in the Midst of Cancer Chemoresistance
Diagnosis and Treatment of Breast Disease—Chaos or Evolution?
Chronic Myeloid Leukemia—Second-generation ABL Kinase Inhibitors and Newly Diagnosed Patients
Current Treatment Standards in Metastatic Colorectal Cancer— The Role of Anti-epidermal Growth Factor Antibodies
Picoplatin in Relapsed Small-cell Lung Cancer
Gastrointestinal Stromal Tumors in the Era of Imatinib—An Overview
Histone Deacetylase Inhibitors and Chronic Myeloid Leukemia
T-cell Immunotherapies for Non-Hodgkin’s Lymphoma and Hodgkin’s Disease
Identifying Cancer Genes—A Review
The Combination of Xanafide and Cytarabine Has Unique Activity in Acute Myeloid Leukemia
State-of-the-art Therapy for Glioblastoma Multiforme
Iron Chelator Therapy
Current Treatment Options in Adult Glioblastoma
Human Papillomavirus Vaccines and the Prevention of Cervical Cancer— The Dawn of a New Era?
Diagnostic Imaging Approaches to Prostate Cancer
High-dose-rate Brachytherapy of Prostate Cancer
Adjuvant Chemotherapy for Early-stage Breast Cancer
Emerging Lymphoma Therapies
The Use of Histone Deacetylase Inhibitors for the Treatment of Solid Tumors
Therapeutic Treatment of Hepatic Colorectal Metastases
First-line Chemotherapy in Patients with Advanced Ovarian Cancer
Advances in the Development of Lung Cancer Vaccines
Multimodality Treatment for Non-small-cell Lung Carcinoma
Advances in Chemotherapy for Metastatic Breast Cancer
Reducing the Incidence and Severity of Oral Mucositis—Can It Be Done?
The International Union Against Cancer
The Treatment of Multiple Myeloma and Myelodysplastic Syndromes with Immunomodulatory Agents
New Hematological Indications for Imatinib
Contemporary Management of Rectal Cancer
Increased Efficacy of Anaemia Treatment in Cancer
The Use of Rituximab in Immune-mediated Anaemia
Assessment of Thrombin Generation
Hypocholesterolaemia in Thalassaemia – Pathogenesis, Implications and Clinical Effects
The Use of Plerixafor for Peripheral Blood Stem Cell Mobilisation Reduces the Frequency of Mobilisation Failure in Patients Planned to Undergo Autologous Transplantation
Myelodysplastic Syndromes – Unexpected Insights Stimulate the Biological Landscape
Iron Overload, Oxidative Damage and Ineffective Erythropoiesis in Myelodysplastic Syndromes
Health Technology Assessment of Multiplex Reverse Transcriptase Polymerase Chain Reaction Screening for Translocations at Diagnosis in Acute Myeloid Leukaemia
Clinical Management of Relapsed/Refractory Acute Myeloid Leukaemia
Deacetylase Inhibition in Haematological Malignancies – Advanced T-cell Lymphoma, Hodgkin’s Lymphoma, Multiple Myeloma, Acute Myelogenous Leukaemia and Myelodysplastic Syndrome
Philadelphia-negative Chronic Myeloproliferative Disorders in Children
The Treatment of Diffuse Large B-cell Lymphoma with Poor Prognosis in the Rituximab Era – State of the Art and Future Perspectives
Progress in the Front-line Treatment of Multiple Myeloma
Diagnosis and Treatment of Erythrocytosis
Imatinib Blood Level Testing – Current Perspectives and Key Questions
The Spectrum of T-cell and Natural Killer – Large Granular Lymphocytic Proliferations
Recurrent Genomic Aberrations in Chronic Lymphocytic Leukaemia – Implications for Disease Pathogenesis and Prognosis
Balancing the Efficacy and Tolerability of First-line Treatment in Elderly Myeloma Patients
The Cancer Stem Cell Concept in Multiple Myeloma – From Phenomenology to Characterisation
Holotranscobalamin – An Early Marker for Laboratory Diagnosis of Vitamin B12 Deficiency
The Management of Paroxysmal Nocturnal Haemoglobinuria – Recent Advances in Diagnosis and Treatment, and New Hope for Patients
Laboratory Diagnostics in Septic Disseminated Intravascular Coagulation
Identification and Functional Characterisation of von Willebrand Disease
Laboratory Diagnosis of von Willebrand Disease
D-dimer Testing and Venous Thromboembolism
Indirect Effects of Cytomegalovirus Infection
Unrelated Transplants for High-risk Adult Acute Lymphoblastic Leukaemia
Oncogenic Anaplastic Lymphoma Kinase Rearrangements in Lymphoma
Myeloproliferative Neoplasms – Classification, Diagnostic and Therapeutic Options in the Light of Molecular Findings
Capturing Alloreactivity in Multiple Myeloma
Recent Developments in Immune Tolerance Induction in Haemophilia A
Risk of Inhibitor Development in Children with Haemophilia A
Treatment of Haemophilia A with Recombinant Antihaemophilic Factor VIII Products
Importance of Pharmacokinetics in the Treatment of von Willebrand Disease
Diagnosis and Management of Inherited Platelet Disorders
Platelet Refractoriness
When Should Congenital Inherited Thrombocytopenia Be Suspected?
First-line Idiopathic Thrombocytopenic Purpura Therapies – Benefits and Limitations
Serum Free Light Chain Assays – Their Role in Multiple Myeloma
Review of the Response Criteria for Myelodysplastic Syndrome
Current and Future Alternatives for Allogeneic Blood Product Transfusions
Intravenous Rhesus Immune Globulin and Intravenous Immunoglobulin in Immune Thrombocytopenic Purpura
Advances in Preventing Cytomegalovirus Disease in Stem Cell Transplant Recipients
Modulating the Interaction of Stromal-cell-derived Factor-1/CXCL12 and its Receptor, CXCR4, for Enhanced Mobilisation, Homing and Engraftment of Haematopoietic Stem Cells
‘Traveller’s Thrombosis’ – Does It Exist and Are We Ready to Give Prophylaxis?
Venous Thromboembolism – The Intersection of Thrombosis and Inflammation
Thalassaemia – A Comparative Analysis Across Europe
Rituximab Therapy for Immune Anaemia and Thrombocytopenia
The Biology of Fanconi Anaemia
Helicobacter pylori and Idiopathic Thrombocytopenic Purpura – Where Do We Stand?
The Emergence of Prophylaxis as the Standard of Care to Treat Joint Bleeding Associated with Von Willebrand Disease
The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients with Hemophilia A with Inhibitors
Recent Clinical Advances in Coagulopathies
Hemophilia with Inhibitors and Surgery
Adeno-associated Viral-mediated Gene Transfer for Hemophilia
Serum Free Light Chain Assays—Their Role in Multiple Myeloma
Intravenous Rhesus Immune Globulin and Intravenous Immunoglobulin in Immune Thrombocytopenic Purpura
Current and Future Alternatives for Allogeneic Blood Product Transfusions
Advances in Preventing Cytomegalovirus Disease in Stem Cell Transplant Recipients
Modulating the Interaction of Stromal-cell-derived Factor-1/CXCL12 and its Receptor, CXCR4, for Enhanced Mobilisation, Homing and Engraftment of Haematopoietic Stem Cells
Bone Marrow Cell Therapy for Cardiovascular Diseases
The Role of Dendritic Cells in Graft-versus-host Disease
Venous Thromboembolism—The Intersection of Thrombosis and Inflammation
Innovative Drug Design Using RNA Aptamers for Various Anemias
The Biology of Fanconi Anemia
Viral Causes of Secondary Immune Thrombocytopenic Purpura
Education, Mentoring, and Collaborative Research—The Mission of the Hemophilia & Thrombosis Research Society
Partial Splenectomy for Hereditary Spherocytosis—What Do We Know and What Do We Need to Know?
The Impact of Factor VIII/von Willebrand Factor Concentrate in Inhibitor Development and Management of Patients with Hemophilia A with Inhibitors
Capturing Alloreactivity in Multiple Myeloma
Snake Venom and Haemostasis – An Overview
Awareness of Mild Bleeding Disorders
Immunological Aspects of Inhibitor Development in Haemophilia
Long-term Prophylaxis in von Willebrand Disease – How Should It Be Given and for Whom?
Current Management of von Willebrand Disease
Congenital Disorders of Platelet Function
Romiplostim – A Thrombopoiesis-stimulating Peptibody for the Management of Chronic Immune Thrombocytopenic Purpura in Adults
Management Based on Residual Vein Thrombosis to Optimise the Duration of Oral Anticoagulants After Deep Vein Thrombosis
Defective Fibrinolysis and Genetic or Acquired Pro-coagulant Changes Synergistically Increase the Risk of Venous Thrombosis
Breaking New Ground in Intravenous Iron Therapy
Innovative Drug Design Using RNA Aptamers for Various Anaemias
Indirect Effects of Cytomegalovirus
Prevention of Mother-to-child Transmission of HIV
Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in Acute Myeloid Leukaemia
The Harmful Effects of Iron Overload in Patients with Myelodysplastic Syndrome
Proteomics in Myeloproliferative Disorders
Peri-operative Goal-directed Haemodynamic Therapy – Why Are We Where We Are Now, and What Is Needed to Move Forward?
Neutralising Pathogens in Blood in Developing Countries – Thinking Outside the Screening Box
Immunopathogenesis, Immunomodulation and Management of Immune Thrombocytopenic Purpura in Children
Arterial-pressure-based Continuous Cardiac Output Monitoring in Paediatric Patients
First-line Treatment of Metastatic Lung Cancer—New Developments
The ECCO–ESMO Collaboration – A Powerful Force in Combating Cancer
Contrast-enhanced Magnetic Resonance Imaging – A Method with Prospects
Treatment of Nausea and Vomiting During Chemotherapy
Percutaneous Instrumentation of Pathologic Vertebral Fractures
The Role of Positron-emission Tomography–Computed Tomography for Prediction of Treatment Response After Chemoradiation for Advanced-stage Head and Neck Cancer
Clinical Utility of Comprehensive Microarray Testing in Early-stage Breast Cancer
Intraoperative Considerations in Sentinel Lymph Node Biopsy for Breast Cancer
Diagnosis of Metastatic Breast Cancer— A Case Report Using Molecular Cancer Classification
Clinical Outcomes of Pediatric Soft-tissue Sarcoma in the Extremities
Internal Hemipelvectomy for Musculoskeletal Tumors— Indications and Options for Reconstruction
Positron Emission Tomography–Computed Tomography Evaluation of Maxillary Rhabdomyosarcoma in an Adult
Positron-emission Tomography Imaging in Breast Cancer
Molecular Monitoring of BCR-ABL Transcripts—Standardization Needed to Properly Use, and Further Investigate the Value of, a Critical Surrogate Marker for Success in Therapy of Chronic Myeloid Leukemia
Treatment Options for Myelodysplastic Syndromes
Von Willebrand Disease Screening in Adolescents with Menorrhagia— A Decision Analysis and Review
Extracellular Hemoglobin Regulation of von Willebrand Factor Activity in Plasma of Patients with Sickle Cell Disease
Allogeneic Hematopoietic Stem Cell Donation— Current Status with Regard to Safety
Thalassemia as a Hypercoagulable State
Quality of Life in Elderly Patients with Urological Malignancies – A Review of Standard Questionnaires
Can an Oncology Information System Improve Radiation Therapy Safety and Patient Confidence?
A Review of Treatment in Non-small-cell Lung Cancer
Symptomatic Spinal Metastases from Intracranial High-grade Glioma – Report of Four Cases and Review of the Literature
Adjuvant Chemotherapy in Patients with Osteosarcoma
What’s New in Gynaecological Oncology?
Fertility-preserving Management of Endometrial Carcinoma
Bronchial Carcinoid Tumours in Children – A Review
Treatment Options for Myelodysplastic Syndromes
Novel Therapy of Relapsed and Refractory Classical Hodgkin’s Lymphoma
Allogeneic Haematopoietic Stem Cell Donation – Current Status with Regard to Safety
Thalassaemia as a Hypercoagulable State
ESMO 2012
The End of Cytotoxics?
A Review of Targeted Therapies in the Management of Advanced-stage Hepatocellular Carcinoma
Future Role of the Gastroenterologist in Digestive Oncology – A European Perspective
Dynamics of Human Papillomavirus and Cervical Cancer Screening
The Role of Imaging in Suspected Prostate Cancer
Management of Metastatic Castration-resistant Prostate Cancer
Review of Data for Monoclonal Antibody-purified Plasma-derived Factor IX
Update on the Management of Febrile Neutropenia
Current Epidemiology and Prevention of Infectious Complications in Cancer Patients
Fifty Years of Progress Against Cancer – The European Organisation for Research and Treatment of Cancer Celebrates its Achievements
The Use of Prophylactic Granulocyte-colony Stimulating Factor for Chemotherapy-induced Febrile Neutropenia
Inflammatory Breast Cancer – Does the Confirmation of Dermal Lymphatic Invasion Predict the Worst Outcome?
Concurrent Chemoradiation in Inoperable, Locally Advanced Non-small Cell Lung Cancer – Comparison of Efficacy and Toxicity in the Elderly
Surgery of the Primary Tumour in Stage IV Colorectal Cancer with Unresectable Metastases
VAL 201 – An Inhibitor of Androgen Receptor-associated Src and a Potential Treatment of Castration-resistant Prostate Cancer
Use of Bendamustine in Chronic Lymphocytic Leukaemia Patients with Co-morbidities
A Review of Sleep Concerns in Paediatric Sickle Cell Disease
Health Status Screening in Elderly Patients – Is this the Way Forward?
Docetaxel Rechallenge in Patients with Castration-resistant Prostate Cancer – A Review
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Obesity in the Elderly – On the Role of Adipokines in Prostate Cancer Progression
Role of 4D Stereotactic Radiotherapy with the CyberKnife® System in the Treatment of Lung Cancer
Advancing the Care of Cancer Patients with Vertebral Compression Fractures—A Radiation Oncology Expert Panel Discussion
INNOVATION IN ONCOLOGY – ECIO 2012
Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures in Cancer Patients
Weighing Bone-targeted Treatment Options for Patients with Solid Tumours and Skeletal Complications from Metastatic Disease
Antitumour Effects of Somatostatin Analogues in the Treatment of Neuroendocrine Tumours
Drug-eluting Beads in the Treatment of Hepatocellular Carcinoma and Colorectal Cancer Metastases to the Liver
Predictive Factors of Efficacy of Sunitinib Therapy in Gastrointestinal Stromal Tumours
Liver Transplantation for Cholangiocarcinoma
The Intriguing Role of Bevacizumab in Advanced Breast Cancer – The Search Continues
Aromatase Inhibitors as Neoadjuvant Treatment in Elderly Patients with Locally Advanced Breast Cancer
Role of 4D Stereotactic Radiotherapy with the CyberKnife® System in the Treatment of Lung Cancer
Microwave Ablation of Lung Tumours – Clinical Update
Stem Cells in Acute Lymphoblastic Leukaemia
Advancing the Care of Cancer Patients with Vertebral Compression Fractures—A Radiation Oncology Expert Panel Discussion
Ethical Dilemmas in Gynecologic Oncology—Practice Points for the Oncology Practitioner
Chemotherapy Options for Metastatic HER2-Negative Breast Cancer after Prior Exposure to Anthracyclines and Taxanes
Basal-like Breast Cancer—Characteristics, Risks, and Associations
Paradigm towards Tailored Therapies and Complete Responses in the Treatment of Metastatic Renal Cell Carcinoma
Concurrent Chemoradiation in Inoperable, Locally Advanced Non-small Cell Lung Cancer—Comparison of Efficacy and Toxicity in the Elderly
Stereotactic Radiotherapy for Liver Metastases
Conventional Pre-operative Chemoradiotherapy and Post-operative Adjuvant Chemotherapy with Induction Chemotherapy Followed by Chemoradiotherapy and Surgery in Locally Advanced Rectal Cancer
Therapeutic Mechanisms of Treatment in Cervical and Vaginal Cancer
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Peri-operative Therapies for Localized Retroperitoneal Soft Tissue Sarcoma
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma
The Role of Complete Blood Cell Count in Prognosis—Watch this Space!
Streamlining Workflows Across Multiple Cancer Centres with the MOSAIQ® Oncology Information System
Ability of the Comprehensive Geriatric Assessment to Predict Frailty in Older People Diagnosed with Cancer in a General Hospital
HIV-associated Thrombotic Thrombocytopenic Purpura – What We Know So Far
Initial Experience with Determination of hTERC and MYCC Amplification in Cervical Intraepithelial Neoplasia and Cervical Carcinoma in the Czech Republic
Meeting Educational Needs and Enhancing Adherence of Patients Receiving Oral Cancer Agents Through Use of the MASCC Oral Agent Teaching Tool©
Bevacizumab Therapy for Choroidal Melanoma
Current Standards and New Trends in Oesophageal Cancer
NGR-hTNF plus Doxorubicin in Recurrent Ovarian Cancer
Treatment of Relapsed or Refractory Multiple Myeloma in the Era of Novel Agents
Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma
Serious Hazards of Transfusion Haemovigilance – The UK Experience
Very Rare Tumours in Paediatric Age – From ‘Tumori Rari in Età Pediatrica’ to the European Cooperative Study Group for Paediatric Rare Tumours
Stem Cells in Epithelial Renewal and Cancer of the Intestine
5-aminosalicylic Acid and Colorectal Cancer Prevention in Inflammatory Bowel Disease
Diagnosis and Management of Barrett’s Metaplasia
Laparoscopic Resection For Colon and Rectal Cancer
Hereditary Colon Cancer
Vaginal Self-collection in Human Papillomavirus Testing
Hysteroscopic Diagnosis of Gynaecological Tumours
The Use of Biomarkers to Guide Treatment Decisions in Non-small-cell Lung Cancer
A Review of Treatment in Non-small-cell Lung Cancer
Techniques in Bronchoscopy
Evidence-based Molecular Profiling for Solid Tumours – The Future is Now
Iron Deficiency Anemia in Cancer Patients
Exercise Recommendations for Cancer-Related Fatigue, Cognitive Impairment, Sleep Problems, Depression, Pain, Anxiety, and Physical Dysfunction—A Review
Recent Developments in Treatments for Metastatic Castration-resistant Prostate Cancer—A Mechanistic Perspective
Effects of Denosumab versus Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer and Bone Metastases
Time for a New Paradigm in the Treatment of Metastatic Melanoma
Carfilzomib—A Selective Proteasome Inhibitor for the Treatment of Relapsed and/or Refractory Multiple Myeloma
The Role of F18-fluorodeoxyglucose Positron Emission Tomography in the Management of Relapsed or Refractory Hodgkin’s Lymphoma
Hodgkin’s Lymphoma in Adolescents and Young Adults
Trauma-related Coagulopathy—Current Concepts
Maintenance Therapy in Non-small-cell Lung Cancer - Review of Rationale, Clinical Need and Available Data
The Use of Biomarkers to Guide Treatment Decisions in Non-small-cell Lung Cancer
The Patient-centred Oncology Information System – Automating your Oncology Workflow For Optimal Patient Care
A Review of Treatment in Non-small-cell Lung Cancer
Optimising Therapeutic Options for Patients with Advanced Pancreatic Neuroendocrine Tumours
Preoperative Treatment of Locally Advanced Rectal Cancer
Treatment of Bone Tumours by Radiofrequency Thermal Ablation – Beyond the Osteoid Osteoma
The Need for a New Fluoropyrimidine in Advanced Gastric Cancer Treatment
Evidence-based Molecular Profiling for Solid Tumours – The Future is Now
The Use of Extracorporeal Photopheresis for the Treatment of Acute Graft Versus Host Disease
Combination Therapy of Cancer – Escalating the Effect of Dendritic Cell-based Cancer Vaccine in the Tumour Micro-environment
Clinical Utility of Autologous Stem Cell Transplantation for Multiple Myeloma in the Era of Novel Agents
Colorectal Cancer – Management of Metastatic Disease
The Potential of Ghrelin in Cancer Anorexia–Cachexia
Castration-resistant Prostate Cancer— Chemotherapies and Molecular Targets
Advances in Adjuvant Therapy for the Treatment of High-risk Melanoma
The Advanced Generation of Oral 5-Fluorouracil Available in Europe – Teysuno® (S-1)
Octreotide – A Review of its Use in Treating Neuroendocrine Tumours
Introduction
Potential Role of Vinflunine in Two-tiered Treatment Strategies – Perioperative and Maintenance Therapy
First-line Systemic Therapy in Patients Ineligible (‘Unfit’) to Receive a Cisplatin-based Regimen – Which Patients? What Needs?
After Failure of Prior Chemotherapy – Cytotoxics, Targeted Agents, Immunomodulation – Current Available Data and Potential Synergistic Combinations with Vinflunine
Esophageal Cancer An Update Review
Aging Influences the Value of Serum Leptin as Prostate Cancer Risk Factor
Castrate-resistant Prostate Cancer - Recent Advances in Therapy and Future Perspectives
Salvage Therapy for Prostate Cancer
Multi-modality Therapy for Rectal Cancer -- Past, Present, and Future
Sorafenib in Non-Small Cell Lung Cancer--Results of Clinical Trials
Combination and Sequencing of Therapies for the Treatment of Metastatic Melanoma
Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinoma
Nab-Paclitaxel versus Docetaxel for the First-line Treatment of Metastatic Breast Cancer
Late Complications of Cancer in Childhood and Adolescence
Prognostic Implications of Cytogenetic Features in Myelodysplastic Syndromes
Supportive and Palliative Oncology -- A New Paradigm for Comprehensive Cancer Care
Personalized Medicine -- Some Things To Consider
The European Cancer Congress 2013 – The Largest Platform for Practice-changing Data in Europe
NGR-hTNF plus Doxorubicin in Relapsed Ovarian Carcinoma
Temporary Ovarian Suppression in the Prevention of Chemotherapy-induced Premature Menopause in Early-stage Breast Cancer Patients
Squamous Cell Carcinoma Arising in a Mature Cystic Teratoma of the Ovary: A Case Series and Review of the Literature
Current Status and New Developments in Breast Cancer Diagnosis and Detection
Castration-resistant Prostate Cancer – Chemotherapies and Molecular Targets
Modern Management of Castration-resistant Prostate Cancer
Radiotherapy Controversies in the Radical Treatment of Soft-tissue Sarcomas of the Limb
Prevention of Cachexia in Cancer
A Review of the Prevention of Nausea and Vomiting Induced by Chemotherapy
Target therapies-induced Cardiotoxicity
Chemotherapy-induced Nausea and Vomiting—Where We Stand Now
Measuring the Quality of Life of Patients with Cancer
Immunologic Therapy of Renal Cell Carcinoma
Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment
Management of Castration Refractory Prostate Cancer in Senior Adults
Gallbladder Cancer—Current Management Options
Technologic Advances in External Beam Radiotherapy for Head and Neck Cancer
Combined Chemoradiation Therapy in the Treatment of Squamous Cell Carcinoma of the Head and Neck—An Evolving Paradigm
New Molecular Targets in Lung Adenocarcinoma
Bevacizumab in the Management of Epithelial Ovarian Cancer
Role of the Comprehensive Geriatric Assessment in an Elderly Consultation
A Review of Liposomal Daunorubicin in the Treatment of Acute Leukemia
The Role of Anaplastic Lymphoma Kinase in Human Cancers
Cancer Survivorship: A Positive Side Effect of More Successful Cancer Treatment
Current Trends and Future Directions in the Management of Delayed Nausea and Vomiting
Patient-reported Outcome Measures for Women with Vulvar Neoplasia – Current Situation and Future Directions
New Developments in Chronic Lymphocytic Leukaemia Diagnosis
Radiation Therapy in Male Breast Cancer
Review of Vinflunine Data and Ongoing Developments in Urothelial Carcinoma
First-line Systemic Therapy in Patients Ineligible (‘Unfit’) to Receive a Cisplatin-based Regimen – Literature Review, Recommendations and Potential Use of Vinflunine in Combination or as Monotherapy
The 9th European Breast Cancer Conference (EBCC-9) – Highlights of the Late-breaking Abstracts
A New Fast-acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain
Immunosuppressed Microenvironment – An Emerging Target in Prostate Cancer Management
Radiation Therapy in Male Breast Cancer
Management of Isolated Nodal Recurrence After Head and Neck Cancer Treatment
Triple Negative Breast Cancer Pathologic Diagnosis and Current Chemotherapy Treatment Options
Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma?
Sequencing of Therapy in Breast Cancer
Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer
Diagnosis and Work-up of Malignant Melanoma in the Age of Fine Needle Aspiration and Molecular Testing
Combination of Hormone Therapy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer—Recent Developments and Update
How Should We Treat Elderly Newly Diagnosed Multiple Myeloma Patients?
Measuring the Quality of Life of Patients with Cancer
How to Select for Preoperative Short-course Radiotherapy, While Considering Long-course Chemoradiotherapy or Immediate Surgery, and Who Benefits?
Neoadjuvant Chemotherapeutic and Targeted Therapies for Early-stage, High-risk Breast Cancer
Primary Central Nervous System Anaplastic Large Cell Lymphoma is an Unusual Brain Tumour
Oncoplasty as the Standard of Care in Breast Cancer Surgery
Lynch Syndrome and Long QT Syndrome – As If One Syndrome is Not Already Enough
Low-dose Interleukin-2 in the Treatment of Autoimmune Disease
Potential Use of Biomarkers to Augment Clinical Decisions for the Early Detection of Breast Cancer
Thrombotic Thrombocytopenic Purpura and Hemolytic Uremic Syndrome in 2014—Current Knowledge and Outcomes with Plasma Exchange
Thyroid Cancer—Risks and Causes
Chronic Myeloid Leukemia— What Else is there Beyond Protein Kinase Inhibitors?
Yoga for the Treatment of Insomnia Among Cancer Patients— Evidence, Mechanisms of Action, and Clinical Recommendations
Current Status of Maintenance Therapy in Multiple Myeloma
EGFR Inhibition in the Treatment of Squamous Cell Carcinoma of the Head and Neck
Recent Developments in Androgen Deprivation Therapy for Locally Advanced Prostate Cancer
Systemic Treatment for Gastrointestinal Stromal Tumor—A State of Art
Future of Radiotherapy Delivery in Rectal Cancer— European and US Approaches
State of the Art in Locally Advanced and Recurrent Non-metastatic Prostate Cancer
Demonstration of Clinical Comparability of the Biosimilar Filgrastim to Neupogen, in Terms of Safety and Efficacy, in Healthy Volunteers and Patients Receiving Myelosuppressive Chemotherapy
A Comprehensive Overview of the Role of Azacitidine in the Management of Myelodysplastic Syndromes and Acute Myeloid Leukaemia
Atlas-based Auto-contouring – Balancing Accuracy with Efficiency in OnQ rts®
Fertility Preservation After Breast Cancer
Personalised Cancer Care – A Global Perspective
Molecular Profiling – Challenges and Perspectives
Single Case of a Complete Response in a Metastatic Urothelial Carcinoma Patient Treated with Zoptarelin Doxorubicin
Head and Neck Cancer Highlights of ESMO Congress 2014
Primary Penile Kaposi Sarcoma in an HIV-negative 21-year-old Male
Darwinian Principles in Cancer Therapy
Defibrotide – A New Treatment Approach for Severe Veno-occlusive Disease
Translating Promising Biomarkers into Oncology Clinical Practice
A Systematic Review of Factors Influencing Older Adults’ Hypothetical Treatment Decisions
Breast Cancer Screening in Older Women— Current Evidence and Future Perspectives
PD-1 and PD-L1 Inhibitors in Advanced Non-small Cell Lung Cancer— Promising Agents and Evolving Questions
How Should We Treat Elderly Newly Diagnosed Multiple Myeloma Patients?
Mucositis—Supportive Care During Radiotherapy or Chemoradiotherapy of Head and Neck Cancer
Chemotherapy-induced Neuropathy—Where Are We Now?
Cancer Pain and Opioids—Past, Present, and Future
Current and Emerging Therapies in Metastatic Prostate Cancer
Two Decades of Progress in the Management of a Rare Disease— Peritoneal Mesothelioma
Gastrointestinal Stromal Tumors (GIST)—Paving the Way for Modern Oncology—Epidemiology, Diagnosis, Treatment
Future of Radiotherapy Delivery in Rectal Cancer— European and US Approaches
Gastrointestinal Stromal Tumors (GIST)—Paving the Way for Modern Oncology—Epidemiology, Diagnosis, Treatment
A Rare Condition in Haematological Practice – Gaucher Disease
Brentuximab Vedotin in Relapsed/Refractory Hodgkin’s Lymphoma
Chronic Myeloid Leukaemia – The Choice of Therapy and Future Perspectives
The Treatment of Chronic Myeloid Leukaemia (CML) in the Era of Tyrosine Kinase Inhibitors – What is New in the Battle of CML?
Precision Medicine in Europe – Forging a Common Vision
Long-term Survival after Cerebellar Metastasis Resection from Her2 3+ Locally Advanced Breast Cancer
Breast Cancer Patients Continue to Struggle for Years After Diagnosis
Gefitinib-induced Acute Kidney Injury in a Patient with Advanced NSCLC Harbouring an EGFR-activating Mutation
Adverse Event Management in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Antibody–Drug Conjugates in Relapsed/Refractory CD30-positive Lymphomas
Grappling with the Data Explosion in Oncology
Trends in the Cost-effectiveness of Chemoprevention for Breast Cancer—2001 to 2015
Why We Need to Continue to Research Ways to Improve the Treatment of Locally Advanced Cervical Cancer
Individualized Treatment of Diffuse Large B-cell Lymphoma— The Evolving Role of Molecular-subtype-specific Therapy
Monoclonal Antibodies for the Treatment of Multiple Myeloma— A New Paradigm
Current and Future Therapeutics for Patients with Non-small Cell Lung Cancer and Known Activating Mutations in Epidermal Growth Factor Receptor
Rociletinib—An Investigational Therapy in Patients with Previously Treated EGFR Mutant-positive Non-small Cell Lung Cancer
Radium223—Where Does It Fit in the Metastatic Castration-resistant Prostate Cancer Treatment Landscape?
American Society of Clinical Oncology 2015— Highlights of Non-colorectal Gastrointestinal Cancers
“New” Drugs in Localized Rectal Cancer
Making Sense of the Advances in the Treatment of Hepatocellular Carcinoma
Managing Immunotherapy-related Side Effects
Genomics and Precision Cancer Medicine
Significance of Ras Signaling in Cancer and Strategies for its Control
Chronic Myeloid Leukaemia – The Choice of Therapy and Future Perspectives
The Treatment of Chronic Myeloid Leukaemia (CML) in the Era of Tyrosine Kinase Inhibitors – What is New in the Battle of CML?
Contribution of the Prosigna® (PAM50) Gene Signature Assay as a New-generation Genomic Test for Treatment Decision-making in Early Breast Cancer
How Do We Move Forward with Vaccines in Lung Cancer?
Adverse Event Management in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Mammalian Target of Rapamycin (mTOR) Inhibition in Advanced Bronchial Carcinoids
Adverse Event Management in Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
Front-line Management of Multiple Myeloma – How Can We Best Assess the Depth of Response?
Therapy for Multiple Myeloma – Quo Vadis?
Pomalidomide – An Appraisal of Its Clinical Development and Role in the Treatment of Relapsed/Refractory Multiple Myeloma
Autologous Transplantation in Relapsed or Refractory Hodgkin’s Lymphoma – The Challenges
Antibody–Drug Conjugates in Relapsed/Refractory CD30-positive Lymphomas
The Use of Brentuximab Vedotin with or without Subsequent Allogeneic Stem Cell Transplantation in Selected Patient Groups
Lenalidomide – A Brief Review of its Use in Myelodysplastic Syndromes
New Treatment Options in Mantle Cell Lymphoma
Hereditary Hyperferritinemia-cataract Syndrome
Myelodysplastic Syndromes – Just a Matter of Age?
Current State of Fertility Preservation in Cancer Patients—What is Established and What is Still Controversial?
Immune Checkpoint Inhibition for Triple-negative Breast Cancer
Biosimilars in Oncology
The Future of Melanoma Immunotherapy
Elevated Coagulation Factor IX and Risk of Thrombosis Development
Recent Updates in the Management of Triple Negative Breast Cancer
Pathways Forward in Candidate Selection for Systemic Therapy in Invasive Urothelial Cancer of the Bladder
Asymptomatic Metastatic Esophageal Cancer Presenting Like Stroke—A Case Report
Is Gastrointestinal Metastasis of Primary Lung Malignancy as Rare as Reported in the Literature? A Comparison Between Clinical Cases and Post-mortem Studies
Cancer Stem Cells and Cancer Stem Cell Inhibitors in Gastrointestinal Cancers
A Clinical Perspective of Adrenocortical Carcinoma
Cancer Stem Cells and Cancer Stem Cell Inhibitors in Gastrointestinal Cancers
Is Knowledge Better than Ignorance in Paediatric Oncogenetics? Identifying Biological Causes and Searching for Meaning
Myelodysplastic Syndromes – The Epigenetic Model for Drug Development?
Supporting Older People with Cancer – Merging Geriatric and Oncological Knowledge
The Two Revolutions in the Treatment of Advanced Non-small Cell Lung Cancer
Developments in Advanced Prostate Cancer in 2016
To Hyperfractionate or not to Hyperfractionate – Is it Really a Question?
Supportive Care of Patients Undergoing Immunotherapy
Bevacizumab in the Treatment of Cervical Cancer – Current Evidence and Next Steps
Genomic Drivers in Breast Cancers
Therapeutic Place of Fulvestrant in the Management of Hormone-receptor Positive Breast Cancer
Tumour Lysis Syndrome in Solid Tumours Associated with Tyrosine Kinase Inhibitors – A Case Illustrated Review
Investigating Rare Haematological Disorders – A Celebration of 10 Years of the Sherlock Holmes Symposia
Sickle Cell Trait and Renal Disease
Cancer Immunotherapy with Interleukin-2— Current Status and Future Developments
Transient Elastography for the Detection of Hepatic Iron Overload in Patients with Myelodysplastic Syndrome
Prevention of Chronic Graft-versus-host Disease and the Unique Role of Anti-human T-lymphocyte Immune Globulin
How to Find the Optimal Mobilisation Strategy – Impact, Challenges and Solutions
Advancing Our Clinical Perspectives in Haematology – What is Your Approach?
An Exciting New Era in the Treatment of Myeloproliferative Neoplasms
Measurable (Minimal) Residual Disease—A Meaningful Biomarker in Multiple Myeloma
Cancer Immunotherapy with Interleukin-2— The PROCLAIMSM Registry
Advances in Colorectal and Anal Cancer Treatment Based Upon Selected ASCO 2016 Presentations— Advances in Immunotherapy and Considering the Site of the Primary Tumor in Treatment Decisions
Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies
Sickle Cell Trait and Renal Disease
Invasive Epiglottic Aspergillosis Mimicking Supraglottic Laryngeal Carcinoma—A Case Report and Review of the Literature
Myelodysplastic Syndromes – The Epigenetic Model for Drug Development?
Developments in Advanced Prostate Cancer in 2016
Tumour Lysis Syndrome in Solid Tumours Associated with Tyrosine Kinase Inhibitors – A Case Illustrated Review
Treatment Update for Women with Hormone Receptor-positive Advanced Breast Cancer
Letter from the Editor-in-Chief
Optimising the Use of Ruxolitinib in Inadequately Controlled Polycythaemia Vera
How to Find the Optimal Mobilisation Strategy – Impact, Challenges and Solutions
Prevention of Chronic Graft-versus-host Disease and the Unique Role of Anti-human T-lymphocyte Immune Globulin
Epigenetics in the Biology and Treatment of Multiple Myeloma
Transient Elastography for the Detection of Hepatic Iron Overload in Patients with Myelodysplastic Syndrome
Triple Negative Breast Cancer—Review of Current and Emerging Therapeutic Strategies
Immune Checkpoint Inhibition for Triple-negative Breast Cancer
Optimising Clinical Outcomes in Gastrointestinal Cancers through Inhibiting Angiogenesis and Other Signalling Pathways
Immunotherapy and Targeted Therapies in the Treatment of Non-small Cell Lung Cancer
Monophasic Synovial Sarcoma of the Infratemporal Fossa—Case Report and Review of the Literature
Expert Opinion on the Treatment of Refractory Chronic Phase Chronic Myeloid Leukaemia
Can We Improve Thyroid Fine-needle Aspiration Cytology Adequacy in a Low-volume Thyroid Center?
Advancing the Management of Non-small Cell Lung Cancer
State-of-the-art Integration of Multikinase Inhibitors in the Treatment of Gastrointestinal Cancers
Combined BRAF and MEK Inhibition with Vemurafenib and Cobimetinib for Patients with Advanced Melanoma
Oncological Scenario in Developing Countries – Little Light at the End of Tunnel
Clinical Development and Manufacture of Chimeric Antigen Receptor T cells and the Role of Leukapheresis
Recent Advances in Multiple Myeloma
Recent Developments in the Therapeutic Landscape in Renal Cancer
Decreasing Lung Cancer Mortality through Screening—The Lung Cancer Alliance Experience
Raising the Bar in Advanced Pancreatic Cancer
Can We Improve Thyroid Fine-needle Aspiration Cytology Adequacy in a Low-volume Thyroid Center?
Development of Checkpoint Inhibitors for Sarcomas
Primary Tumor Location Implications on Biological Therapy in Metastatic Colorectal Cancer
Current and Emerging Drug Therapies in Chronic Lymphocytic Leukemia
Paraneoplastic Syndromes in Children with Hodgkin Lymphoma
Targeting Cancer Stem Cells—A Renewed Therapeutic Paradigm
Metastatic Prostate Cancer Manifesting as Cavernous Sinus Syndrome—Case Report and Review of the Literature
Adenocarcinoma in situ of the Cervix – is Loop Electrosurgical Excision Procedure an Acceptable Alternative to Cold Knife Cone Biopsy?
The Management of Chronic Myeloid Leukaemia (CML) Patients with Refractory Disease – Focusing on the Opinions of CML-treating Physicians
Enabling T Cell Recruitment to Tumours as a Strategy for Improving Adoptive T Cell Therapy
Molecular Diagnostics in Breast Cancer Routine Practice
Plasmacytic Post-transplant Lymphoproliferative Disorder – Case Report
Targeting the FLT3 Mutation in Acute Myeloid Leukaemia
Can we Continue to Afford Access to Cancer Treatment?
What Happens when the Cost of Cancer Care Becomes Unsustainable?
Endocrine Therapeutic Strategies for Patients with Hormone Receptor-positive Advanced Breast Cancer
Call for Submissions
Targeted and Immune Therapies in Non-small Cell Lung Cancer—Latest Advances
Pearls for Prostate Cancer Screening
Cytogenetic, Inflammatory, Immunologic, and Infectious Basis for Dysplastic Hematopoeisis
Adrenal Oligometastases Secondary to Non-small Cell Lung Cancer—What is the Optimal Treatment Approach?
Updates in Adult Acute Lymphoblastic Leukemia—Current Status of Antigentargeted Treatments and Immunotherapy
Metastatic Uveal Melanoma—A Review of Current Therapies and Future Directions
Breaking the Barrier—PEGylated Recombinant Human Hyaluronidase (PEGPH20)—A New Therapeutic Approach to the Treatment of Pancreatic Ductal Adenocarcinoma
The Changing Therapeutic Landscape in Metastatic Prostate Cancer
Call for Submissions 2018
Potential Solutions for Sustaining the Costs of Cancer Drugs
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
Systemic Chemotherapy for Urothelial Cancer – How to Select Systemic Therapy in Bladder Cancer
Bmi1 – A Path to Targeting Cancer Stem Cells
Exercise for Toxicity Management in Cancer—A Narrative Review
Erratum to: Cytogenetic, Inflammatory, Immunologic, and Infectious Basis for Dysplastic Hematopoeisis
The Impact of Biosimilars in Supportive Care in Cancer
More than a Gel – Hyaluronic Acid, a Central Component in the Microenvironment of Pancreatic Cancer
Rolapitant in the Current Management of Chemotherapy-induced Nausea and Vomiting
The Belarus Experience of Pelvic Artery Embolisation in Patients with Advanced and Recurrent Cervical Cancer Presenting with Haemorrhage
Radiopharmaceuticals for the Detection of Recurrent Prostate Cancer
Advances in Cancer Research and Translational Medicine
Detecting an ALK Rearrangement via Liquid Biopsy Enabled a Targeted Therapy-based Approach for Treating a Patient with Advanced Non-small Cell Lung Cancer
New advances in the treatment of non-small-cell lung cancer?
Changing Paradigms in the Treatment of Renal Cancer

Out Now

European Oncology & Haematology Volume 13 Issue 2 - Winter 2017
Oncology & Hematology - Review Volume 13 Issue 2 - Fall 2017
European Oncology & Haematology - Volume 13 Issue 1 - Summer 2017

LATEST TWEETS

Follow @touchOPHTHALMIC
Tweets by @touchOPHTHALMIC

LATEST TESTIMONIAL

In Partnership

  • compliance-hub

QUICK LINKS

  • Home
  • About
  • Journals
  • Editorial Board
  • Articles
  • Videos
  • Media Partners
  • Press Releases
  • Permissions

Contact Us

  • t: +44 (0) 121 250 3885
  • f: +44 (0) 121 260 60001

Search Site

Search form

RSS Links

  • Latest Articles
  • Editors Choice Articles
  • Latest Journals

CONNECT WITH US & JOIN THE DEBATE...

  • Facebook
  • Twitter
  • Linkedin
  • Google+
OTHER WEBSITES FROM
Copyright® 2018 Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House,
Mill Road, Goring-on-Thames, Reading, England, RG8 9DD with registered number 08197142. All rights reserved.   Privacy Policy     Website Use Terms and Conditions
Touch Oncology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.
close